Pharmidex attending SMR Meeting 'New Developments in Transnational Technologies'

March 17, 2016

SMR meeting focusing on Translational technologies on the 17th of March 2016

Pharmidex will be attending the SMR meeting entitled New Developments in Translational Technologies.

This years meeting focus is very much inline with Pharmidex areas of operation and interest. We look forward to seeing you there on the 17th of March 2016

Modern drug discovery undergoes continual change in our efforts to more effectively design new life changing therapeutics for patients. One area that has seen a massive increase in focus in recent years has been the need for more translational approaches to many if not all therapeutic areas.

This has stemmed from the increasing appreciation that many of the cellular and animal models, traditionally used for the assessment of efficacy, currently have limited predictive validity to the human diseases we are trying to treat. Additionally, target selection based solely on preclinical validation may be leading to flawed biological hypothesise for putative therapeutics. Together these factors have contributed to the poor clinical success rate in many diseases. As a result there has been an increased focus on identify targets based on a strong understanding of human genetics and disease biology. Additionally drug discovery teams are increasingly co- developing translational approaches to demonstrate target engagement and proof of pharmacology whilst identifying biomarkers to stratify patient populations in which to optimally test proof of concept.

This meeting brings together experts from a variety of imaging and preclinical model backgrounds across a range of diseases (dementia, pain and oncology) to present and discuss their experiences in the various aspects of translational science. This promises to be an exciting and interesting meeting with in depth discussion into how the drug discovery community can better target disease processes, more optimally test novel therapeutics in appropriate populations and ultimately enhance clinical success in producing efficacious therapeutics for patients.

Please see the link for further details: http://www.smr.org.uk/SMR/Meetings/20160317/Default.asp

< Older Post

Newer Post >

🔬 Toxicology Studies in the UK – Fast, Flexible & Competitive

January 14, 2026

At Pharmidex , we offer In Vivo (Non-GLP & GLP), In Vitro, and Organ-on-Chip toxicology, alongside our full range of non-GLP and GLP toxicology studies delivered in the UK, with quick turnaround times and UK-competitive pricing. Our experienced team supports your programme from study design through delivery, helping you generate high-quality, decision-ready data efficiently and cost-effectively. 📍 UK-based studies ⚡ Rapid timelines 💷 Competitive pricing 🧪 In Vivo (Non-GLP & GLP), In Vitro & Organ-on-Chip toxicology Learn more: www.pharmidex.com

🎓 Pharmidex at RSC BMCS Postgraduate Symposium XIX 🎓

January 8, 2026

We’re pleased to share that Martin Barrett from Pharmidex will be attending the R SC-BMCS Postgraduate Symposium XIX – Biological and Medicinal Chemistry Symposium for Postgraduates. 📅 Thursday 8th January 2026 📍 MIB Building, Manchester Martin will be presenting at the symposium and representing Pharmidex to discuss our services and capabilities in drug discovery and development. He would be delighted to meet and chat with attendees, explore new ideas, and discuss potential collaborations and partnerships. If you’re attending, please come and say hello! 🌐 www.pharmidex.com 🔗 https://www.rscbmcs.org/events/psxix/

🔬🧪 We’re hiring in Bioanalysis at Pharmidex (Hatfield, UK)!

January 5, 2026

We’re excited to expand our Bioanalytical team and are currently recruiting for two on-site, full-time roles supporting regulated and non-regulated programmes across small and large molecules: 1 - Technical Specialist, Bioanalysis (LC-MS) This is a senior technical authority role for an experienced LC-MS/MS scientist who enjoys solving complex analytical challenges and shaping technical direction. You’ll lead advanced method development and validation, support regulated studies, and mentor other scientists within a collaborative CRO environment. Ideal for candidates with: 5+ years of hands-on LC-MS/MS bioanalytical experience Strong expertise in method development, validation, and troubleshooting Experience with peptides, oligonucleotides, and large molecules Solid knowledge of GLP/GCP bioanalysis CRO experience (strongly preferred) 2 - Bioanalytical Scientist (Regulatory Studies) This role suits a hands-on bioanalytical scientist with experience delivering high-quality data for GLP/GCP studies. You’ll be involved across the full bioanalytical workflow, from method development to reporting, working closely with internal teams and (depending on experience) clients. Ideal for candidates with: A degree in Chemistry or a related discipline 5+ years’ experience in a bioanalytical laboratory Proven experience supporting GLP and/or GCP studies Strong LC-MS, sample preparation, and large-molecule expertise Experience with peptides and oligonucleotides ✨ Why Pharmidex? At Pharmidex, you’ll join a science-driven CRO where quality, accountability, and technical excellence matter. These roles offer real impact, strong collaboration, and the opportunity to contribute to diverse therapeutic programmes. 📩 Interested? Please, check the full offers detail at https://www.pharmidex.com/careers-at-pharmidex and send your CV and a short cover note to [email protected] Feel free to share or tag anyone who might be a great fit!